ERDF — INSERM — Support to research projects — Project “Immunotherapy targeting tPA/NMDA receptor interaction for the treatment of central nervous system pathologies” (Invest) (Q3673447)

From EU Knowledge Graph
Revision as of 15:57, 24 November 2021 by DG Regio (talk | contribs) (‎Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string)
Jump to navigation Jump to search
Project Q3673447 in France
Language Label Description Also known as
English
ERDF — INSERM — Support to research projects — Project “Immunotherapy targeting tPA/NMDA receptor interaction for the treatment of central nervous system pathologies” (Invest)
Project Q3673447 in France

    Statements

    country
    France
    0 references
    EU contribution
    23,500.00 Euro
    0 references
    budget
    47,000.0 Euro
    0 references
    co-financing rate
    50.0 percent
    0 references
    start time
    1 September 2014
    0 references
    end time
    28 February 2019
    0 references
    beneficiary name (string)
    EPA INSERM INSTITUT NAT DE LA SANTE ET DE LA RECHERCHE MEDICALE
    0 references
    beneficiary
    Q3764450
    0 references
    postal code
    75654
    0 references

    Identifiers

    French Kohesio ID
    15P05051
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q3673447&oldid=15912763"